Cegedim Dendrite acquires Health Direction

In a move that will see it expand further into the health care and UK National Health Service sectors, France-headquartered Cegedim Dendrite, a leading provider of customer relationship management software and data to the pharmaceutical industry, has acquired UK-based Health Direction, a provider of NHS business intelligence.

The combination creates the most comprehensive view of the UK health care market available, says the firm, integrating the complete Health Direction database with the combined OneKey and Pharbase databases from Cegedim Dendrite. This new database will also be integrated with other Cegedim UK databases, combining sales and prescription data at PCT, commissioning group and practice level as well as at an individual level. This in turn will enable far more qualified and in-depth analysis to be undertaken. With the NHS going through an unprecedented level of upheaval in the way it delivers health care to local areas, Cegedim Dendrite's market intelligence solutions will play a crucial role in assisting both pharmaceutical clients and the NHS itself to develop the necessary solutions to navigate through this period of change, and maximize their return on investment, the company claims.